Literature DB >> 17961939

Effects of dietary equol administration on ovariectomy induced bone loss in Sprague-Dawley rats.

Dominik Rachoń1, Dana Seidlová-Wuttke, Tina Vortherms, Wolfgang Wuttke.   

Abstract

UNLABELLED: Oestrogen deficiency leads to a considerable bone loss, thus, osteopenia and osteoporosis are serious complications after menopause.
OBJECTIVES: To evaluate the effects of a daidzein metabolite equol on bone mass density (BMD) and markers of bone remodelling in an ovariectomized (ovx) rat model of postmenopausal bone loss and compare them with the effects of 17beta-estradiol.
METHODS: Twenty-eight female Sprague-Dawley rats were ovx and fed soy-free chow only (control group, n = 8), or with the addition of oestradiol-3 benzoate (E2B) (10mg/kg, n = 10) or equol (400 mg/kg, n = 10). At baseline and after 6-week treatment period, proximal tibia and lumbar spine BMD were measured using computer tomography. Animals were then sacrificed, blood was collected and uteri were removed.
RESULTS: Similarly to E2B, dietary equol decreased weight gain and showed mild uterotropic activity. E2B attenuated ovx induced BMD loss at proximal tibia whereas equol had no effect. At lumbar spine, however, equol not only attenuated trabecular bone loss but also increased its density. This effect was also apparent in animals treated with E2B. Cortical BMD at proximal tibia and lumbar spine were not very much influenced by ovx and treatment with E2B or equol did not induce significant changes at these sites. Plasma osteocalcin and type I collagen fragments (cross-laps) in equol treated animals did not differ from the controls whereas in E2B treated animals they were both significantly decreased.
CONCLUSIONS: In spite of its mild uterotropic potential, dietary equol shows limited bone sparing effects in ovx rats.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17961939     DOI: 10.1016/j.maturitas.2007.09.005

Source DB:  PubMed          Journal:  Maturitas        ISSN: 0378-5122            Impact factor:   4.342


  10 in total

1.  Contribution of a membrane estrogen receptor to the estrogenic regulation of body temperature and energy homeostasis.

Authors:  Troy A Roepke; Martha A Bosch; Elizabeth A Rick; Benjamin Lee; Edward J Wagner; Dana Seidlova-Wuttke; Wolfgang Wuttke; Thomas S Scanlan; Oline K Rønnekleiv; Martin J Kelly
Journal:  Endocrinology       Date:  2010-08-04       Impact factor: 4.736

Review 2.  Membrane-initiated actions of estradiol that regulate reproduction, energy balance and body temperature.

Authors:  Martin J Kelly; Oline K Rønnekleiv
Journal:  Front Neuroendocrinol       Date:  2012-08-01       Impact factor: 8.606

Review 3.  Equol: pharmacokinetics and biological actions.

Authors:  Kenneth D R Setchell; Carlo Clerici
Journal:  J Nutr       Date:  2010-06-02       Impact factor: 4.798

4.  Effect of dihydrotestosterone, 17-β-estrogen, genistein and equol on remodeling and morphology of bone in osteoporotic male rats during bone healing.

Authors:  Philipp Kauffmann; Anna Rau; Dana Seidlová-Wuttke; Hubertus Jarry; Boris Schminke; Swantje Matthes; Karl Günter Wiese
Journal:  Bone Rep       Date:  2020-07-28

5.  Supplemental dietary racemic equol has modest benefits to bone but has mild uterotropic activity in ovariectomized rats.

Authors:  Leecole L Legette; Berdine R Martin; Mohammad Shahnazari; Wang-Hee Lee; William G Helferich; Junqi Qian; David J Waters; Alireza Arabshahi; Stephen Barnes; Jo Welch; David G Bostwick; Connie M Weaver
Journal:  J Nutr       Date:  2009-08-26       Impact factor: 4.798

6.  Influence of estradiol supplementation on neuropeptide Y neurotransmission in skeletal muscle arterioles of F344 rats.

Authors:  Kirk W Evanson; Audrey J Stone; Enoch Samraj; Tyler Benson; Rhonda Prisby; Heidi A Kluess
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2012-07-25       Impact factor: 3.619

7.  (±)-Equol does not interact with genistein on estrogen-dependent breast tumor growth.

Authors:  Huaxin Song; Jennifer R Hughes; Russell T Turner; Urszula T Iwaniec; Daniel R Doerge; William G Helferich
Journal:  Food Chem Toxicol       Date:  2019-11-28       Impact factor: 6.023

Review 8.  Soy Isoflavones and Osteoporotic Bone Loss: A Review with an Emphasis on Modulation of Bone Remodeling.

Authors:  Xi Zheng; Sun-Kyeong Lee; Ock K Chun
Journal:  J Med Food       Date:  2015-12-15       Impact factor: 2.786

9.  Pharmacokinetics of equol, a soy isoflavone metabolite, changes with the form of equol (dietary versus intestinal production) in ovariectomized rats.

Authors:  LeeCole L Legette; Jeevan Prasain; Jennifer King; Ali Arabshahi; Stephen Barnes; Connie M Weaver
Journal:  J Agric Food Chem       Date:  2014-01-29       Impact factor: 5.279

10.  Developmental and Reproductive Effects of SE5-OH: An Equol-Rich Soy-Based Ingredient.

Authors:  Ray A Matulka; Ikuo Matsuura; Tohru Uesugi; Tomomi Ueno; George Burdock
Journal:  J Toxicol       Date:  2008-12-15
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.